Results 211 to 220 of about 17,658 (223)

Phase I Study of Weekly Nab-Paclitaxel + Weekly Cetuximab + Intensity-Modulated Radiation Therapy (IMRT) in Patients With Stage III–IVB Head and Neck Squamous Cell Carcinoma (HNSCC)

Annals of Oncology, 2014
J L Lee, D G Pfister, D Y Gelblum
exaly  

Increased Survival in Pancreatic Cancer With Nab-Paclitaxel Plus Gemcitabine

New England Journal of Medicine, 2013
David Goldstein, Daniel A Laheru, Nathan Bahary   +2 more
exaly  

Real-World Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX in Advanced Pancreatic Cancer: A Systematic Review

Therapeutic Advances in Medical Oncology, 2019
Winson Y Cheung, Guido Giordano, Elena Gabriela Chiorean   +2 more
exaly  

Neoadjuvant Nab-Paclitaxel Plus Gemcitabine Followed by Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Randomized Phase 3 Trial

Cancer Cell
Guoliang Qiao
exaly  

Nab-Paclitaxel in the Treatment of Metastatic Breast Cancer: A Comprehensive Review

Expert Review of Clinical Pharmacology, 2011
C Marcela Díaz-Montero, Alberto J Montero, Stefan Glück   +2 more
exaly  

A Phase 2 Clinical Trial of Nab-Paclitaxel in Previously Treated and Chemotherapy-Naive Patients With Metastatic Melanoma

Cancer, 2010
Michael Gordon, Antoni Ribas, Steven J O'Day   +2 more
exaly  

[FOLFIRINOX, nab-paclitaxel + gemcitabine].

Nihon rinsho. Japanese journal of clinical medicine, 2015
openaire   +1 more source

Relacorilant and Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer (ROSELLA): An Open-Label, Randomised, Controlled, Phase 3 Trial

Lancet, The
Mariana Scaranti, Grazia Artioli, Iulia Cristina Tudor   +2 more
exaly  

Nab-paclitaxel licensed for advanced pancreatic cancer

The Pharmaceutical Journal, 2014
openaire   +1 more source

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

Case Medical Research, 2019
openaire   +1 more source